GlassScriptPhysician profile
Barbara Ann Washington
NPI 1639117799
$2,826.57
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $339 · 2021: $766 · 2022: $374 · 2023: $636 · 2024: $96.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $775.33 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $286.97 | 2019-2023 | Eliquis, Camzyos |
| Amgen INC. | $283.87 | 2019-2023 | Repatha |
| Pfizer INC. | $268.16 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $217.77 | 2019-2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $149.52 | 2019-2024 | Lifevest |
| Merck Sharp & Dohme LLC | $137.82 | 2021-2023 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $130.39 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $108.91 | 2019-2022 | |
| Amarin Pharma, INC. | $91.01 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $73.11 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $70.18 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.19 | 2023 | |
| Novo Nordisk INC | $34.81 | 2020-2023 | Wegovy |
| Philips North America LLC | $34.02 | 2020-2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $19.93 | 2022 | |
| Daiichi Sankyo INC. | $18.50 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $17.10 | 2023 | Arcalyst |
| Amryt Pharma Holdings LTD | $16.27 | 2022 | |
| Bardy Diagnostics, INC. | $15.55 | 2022 | |
| Braemar Manufacturing, LLC | $15.39 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.80 | 2019 | |
| Astellas Pharma US INC | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Washington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.